For more, go here. One study of children with achondroplasia found that 100 percent of them commando crawled when they first started crawling. As a parent, I didn’t know what to think.

Of the many developmental milestones that are exciting to parents, few are as memorable as when a baby starts crawling. He or she can now explore and discover, which allows parent and child to ...

Achondroplasia dwarfism is the most common type of skeletal dysplasia. It’s the cause for 90% of cases of markedly short stature in people. Achondroplasia targets bone growth in the arms and legs.

Achondroplasia is a type of dwarfism that affects the growth in children, leading to a short stature or small size. Achondroplasia is a rare genetic condition that affects one in every 15,000 to ...

“The goal of this comprehensive resource is not only to share knowledge about the medical impacts of living with achondroplasia, but to provide families with the tools they need to empower ...

In this phase 2 dose-finding study, we evaluated the safety and efficacy of oral infigratinib in children with achondroplasia between the ages of 3 and 11 years. A total of 72 children were ...

The couple has three children, Jackson, Lilah and Josiah, that were born with achondroplasia, the most common form of short-limbed dwarfism Kimberlee Speakman is a digital writer at PEOPLE.

Infigratinib increased annualized height velocity for children with achondroplasia in a phase 2 trial. BridgeBio Pharma is currently enrolling children with achondroplasia for a phase 3 trial.

The oral FGFR1-3 selective tyrosine kinase inhibitor infigratinib was found to be safe and effective at the highest studied dose among children with achondroplasia in a phase II dose-finding study.